Status:
COMPLETED
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Colon Carcinoma
Eligibility:
All Genders
19-90 years
Phase:
NA
Brief Summary
This clinical quality improvement study reviews and develops a clinical operations workflow to identify cancer patients who meet criteria for genetic counseling and testing. This study may improve uti...
Detailed Description
OUTLINE: Medical oncologists at Olympic Medical Center (OMC) participated in this study and received a peer coaching intervention during phase II to help identify patients who meet criteria for geneti...
Eligibility Criteria
Inclusion
- Medical oncology providers at OMC who see patients with an active diagnosis of breast, ovarian, prostate, colon, or pancreatic cancer
Exclusion
- OMC providers who do not see patients with an active diagnosis of cancer
- OMC providers who see patients who are minors
- OMC providers who see patients with precancerous lesions such as ductal carcinoma in situ (the presence of abnormal cells inside a milk duct in the breast) or colon polyps (a small clump of cells that form on the lining of the colon or rectum)
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04902144
Start Date
August 3 2020
End Date
December 31 2021
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Olympic Medical Cancer Center
Sequim, Washington, United States, 98382